Cendakimab (Anti-IL-13)

Cendakimab (anti-IL-13) is a humanized, recombinant monoclonal antibody against the interleukin-13 (IL-13) molecule with the potential to treat allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis). MW: 146.44 KD.

• Supplier: Selleck Chemicals
• Product #: A2949
• Sku #: A2949-1mg*5